|The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups|
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
|The clonal and mutational evolution spectrum of primary triple-negative breast cancers|
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
|Analysis of circulating tumor DNA to monitor metastatic breast cancer|
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
|The landscape of cancer genes and mutational processes in breast cancer|
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
|Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA|
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
|MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype|
C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...
Genome biology 8 (10), R214, 2007
|Differential oestrogen receptor binding is associated with clinical outcome in breast cancer|
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
|Mutations truncating the EP300 acetylase in human cancers|
SA Gayther, SJ Batley, L Linger, A Bannister, K Thorpe, SF Chin, Y Daigo, ...
Nature genetics 24 (3), 300-303, 2000
|The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes|
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 1-16, 2016
|EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer|
L Hughes-Davies, D Huntsman, M Ruas, F Fuks, J Bye, SF Chin, J Milner, ...
Cell 115 (5), 523-535, 2003
|The shaping and functional consequences of the microRNA landscape in breast cancer|
H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ...
Nature 497 (7449), 378-382, 2013
|High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer|
SF Chin, AE Teschendorff, JC Marioni, Y Wang, NL Barbosa-Morais, ...
Genome biology 8 (10), R215, 2007
|Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer|
KB Meyer, AT Maia, M O'Reilly, AE Teschendorff, SF Chin, C Caldas, ...
PLoS biology 6 (5), 2008
|Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling|
Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ...
Science translational medicine 4 (157), 157ra143-157ra143, 2012
|Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer|
M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ...
Nature communications 6 (1), 1-6, 2015
|Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor|
H Mohammed, C D’Santos, AA Serandour, HR Ali, GD Brown, A Atkins, ...
Cell reports 3 (2), 342-349, 2013
|FUS/ERG gene fusions in Ewing’s tumors|
DC Shing, DJ McMullan, P Roberts, K Smith, SF Chin, J Nicholson, ...
Cancer research 63 (15), 4568-4576, 2003
|Germline CDH1 deletions in hereditary diffuse gastric cancer families|
C Oliveira, J Senz, P Kaurah, H Pinheiro, R Sanges, A Haegert, G Corso, ...
Human molecular genetics 18 (9), 1545-1555, 2009
|Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer|
G Ha, A Roth, D Lai, A Bashashati, J Ding, R Goya, R Giuliany, J Rosner, ...
Genome research 22 (10), 1995-2007, 2012
|Identification and validation of prognostic markers in breast cancer with the complementary use of array‐CGH and tissue microarrays|
G Callagy, P Pharoah, SF Chin, T Sangan, Y Daigo, L Jackson, C Caldas
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005